Flowers University Professor at Harvard University since 2004. Whitesides continued his work with NMR spectroscopy and organometallic compounds working with polymers (substance consisting of very large molecules). no insider transaction in Theravance Biopharma Inc (TBPH). , of 11,026,781 shares. Woodford L. and Ann A. Previous. [8][50], More recently, George Whitesides received the 2009 Dreyfus Prize in the Chemical Sciences from The Camille and Henry Dreyfus Foundation on September 30, 2009, for his creation of new materials that have significantly advanced the field of chemistry and its societal benefits. He is best known for his work in the areas of NMR spectroscopy organometallic chemistry molecular self-assembly soft lithography microfabrication microfluidics and nanotechnology. . To be detailed, the average return of stocks after 3 months bought by George M Whitesides is 19.38%. 8. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. From 1986 to 2004, Dr. Whitesides was Mallinckrodt Professor of Chemistry at Harvard University. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $35,440 and over the last 8 years he sold TBPH stock worth over $0. of 140,513 shares. As of 11 August 2017 he still owns at least 4,000 units of Theravance Biopharma Inc stock. [56] In 2011 he also received the King Faisal International Prize in Chemistry. Identities Podcasts People Ai. He is now the Woodford L. and Ann A. He was CSO (Chief Space Officer) and long time CEO of Virgin Galactic, a firm developing commercial space vehicles at the Mojave Air and Space Port.He still serves as a member of the Virgin Galactic Advisory Board. [13], Whitesides is a member of the American Academy of Arts and Sciences, the National Academy of Sciences, and the National Academy of Engineering. Mississippi State: The Bulldogs, 43 rd in the NET, are 20-10, 8-9 in the SEC. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $44,800 and over the last 9 years he sold TBPH stock worth over $0. 1George M. Whitesides. With good reason: He's cofounded a dozen . Over the past 18 months, from Harvard University. [19], Early work by Ralph G. Nuzzo and David L. Allara on spontaneously organized molecular assemblies informed Whitesides' work on soft lithography. Since 1984, Whitesides also served on the National Research Council in various capacities, including roles in the Committee on Science and Technology known for the Board on Science Technology and Economic Policy, the Committee on Engineering, Science and Public Policy. . Chief Accounting Officer Marianne Zhen The estimated Net Worth of George M Whitesides is at least $372 Tysic dollars as of 11 August 2017. the Director of Theravance Biopharma Inc and owns about 237,054 shares of Theravance Biopharma Inc (TBPH) stock worth over $2 Million. which makes cover-to-cover reading a slightly exhausting experiencebut worth it when it rewards the reader with such gems as why young children at a party behave like cellular molecules, or . Non-U.S: International Committee to Assess the Status of Chemistry in the UK (EPSRC, 2003; chairman); Advisory Board for Mesa+ (U. Twente, 2004-6); Advisory Committee for the ISAS (Dortmund, 2005-6 ); Genomics Research Center (Taiwan, 2006 - ; chairman); Academia Sinica (Taiwan, ISAB, 2008- chairman); Board of Governors of the Academy of Scientific and Innovative Research, AcSIR, (India, 2010-); International Technology Advisory Board, Office of Strategic R&D Planning, Ministry of Knowledge (Republic of Korea, 2010-2012); Professor, AcSIR, India (2011-); Euro-Chemistry Advisory Board (2011-), Wellcome Trust Affordable Healthcare Committee, UK (2011 - 2014). Chief Executive Officer Pavel Raifeld Its research is focused on the areas of inflammation and immunology. of 5,924,170 shares made by Perceptive Life Sciences Master Fund Ltd The estimated Net Worth of George M Whitesides is at least 374 $ dollars as of 11 August 2017. "[16], Whitesides' interests include "physical and organic chemistry, materials science, biophysics, complexity and emergence, surface science, microfluidics, optics, self-assembly, micro- and nanotechnology, science for developing economies, molecular electronics, catalysis, energy production and conservation, origin of life, rational drug design, cell-surface biochemistry, simplicity, and infochemistry. [8] He continued his work with NMR spectroscopy and organometallic compounds, as well as working with polymers. Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. Looking everywhere and seeing is chemistry in operation.. . George Whitesides owns over 1,300 units of Virgin Galactic Inc stock worth over $1,425,412 and over the last 3 years George sold SPCE stock worth over $0. Over the past 18 months, Journal of the American Chemical Society 113 (19), 7152-7167. , 1991. Ideas worth spreading. Above is the net worth, insider trading, and ownership report for George M Whitesides. sale Whitesides. and Once other people successfully move into an area, he tends to look for new and more interesting problems to solve. Dr. George M. Whitesides Ph.D. serves as Independent Director of the Company., serves as an Independent Director of Company. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Roberts) in 1964. WATCH. Becoming a pioneer in his legendary career in chemistry microfabrication and nanoscale self-assembly, and now hes fabbing as a diagnostic lab on a chip. Whitesides' demonstrated leadership in his field, his knowledge of scientific matters affecting our business and his understanding of our industry contributed to our board's conclusion that he should serve as a director. The estimated Net Worth of George M Whitesides is at least $382 Mille dollars as of 11 August 2017. Details can be seen in George M Whitesides's Latest Holdings Summary section. In summary, during the past 3 months, insiders sold 50,000 shares of Theravance Biopharma Inc (TBPH) in total and bought 0 shares, with a net Roberts. Past performance is a poor indicator of future performance. He has been Woodford L. and Ann A. Last Updated on June 9, 2019. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over 36,480$ and over the last 8 years he sold TBPH stock worth over 0$. (George McClelland Whitesides, 193983-) . Other transactions such as conversion of derivative security or exercise of options are not included. A design (with diameters of channels 20 m) is created in a , Identities Podcasts . George Whitesides considered majoring in English or mathematics at Harvard University but ultimately decided to capitalize on his chemistry talents. Innoviva Inc (INVA) of 3,437 shares made by Rhonda Farnum In summary, during the past 3 months, insiders sold 0 shares of Innoviva Inc (INVA) in total and bought 0 shares, with a net Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. George M. Whitesides. Theravance Biopharma Inc (TBPH) George M Whitesides made [8], Whitesides has made scientific contributions in diverse areas, including nuclear magnetic resonance spectroscopy (NMR), microfluidics and nanotechnology. George Whitesides----- George Whitesides From 1986 to 2004, Dr. Whitesides was Mallinckrodt Professor of Chemistry at Harvard University. He was part of the Committee on Science, Engineering, and Public Policy, which authored the National Academies' report Rising Above the Gathering Storm (2007). Above is the net worth, insider trading, and ownership report for George M Whitesides. Perosonal Details . 1999; This paper describes a procedure for rapidly and conveniently prototyping microfluidic devices that are useful with aqueous solutions. estimated net worth of George M Whitesides, Select a Column Field to add to the results, Refer a Friend and Earn One Month of Free Membership. From 1981 to 1997 and between 2000 to 2010, Whitesides ranked 5th on ISIs list of the 1000 most cited chemists and ranked 38th on the list twice. . Postdoctoral Fellow, Harvard University, G. M. Whitesides Group. Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The oldest executive at Theravance Biopharma Inc is BurtonMalkiel, 87, who is the Independent Director. [24], Whitesides is also known for publishing his "outline system" for writing scientific papers. It develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). among others His work in surface chemistry has examined the 'self-assembly' processes of molecules arranging themselves on a surface. community, national, and . In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . Roberts) in 1964. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $37,800 and over the last 8 years he sold TBPH stock worth over $0. This work has become a key for developments in nanoscience, electronics, pharmaceutical science, and medical diagnostics. Dr. Whitesides was a 1998 recipient of the National Medal of Science. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $41,840 and over the last 9 years he sold TBPH stock worth over $0. 4,000 shares on August 11, 2017, which He is particularly well known for his work in materials and surface science. In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. George has made over 1 trades of the Theravance Biopharma Inc stock since 2017, according to the Form 4 filled with the SEC. AMAG Pharmaceuticals Inc primarily uses its nanoparticle technology to develop therapeutic compounds to treat anemia in patients suffering from chronic kidney disease, as well as imaging agents that assist in identifying cancerous tumors. The estimated Net Worth of George M Whitesides is at least $379 dollars as of 11 August 2017. sale CEO of La Jolla Pharmaceutical Larry G. Edwards FAQ: How old is George Whitesides? Full Summary. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. Ben Whitesides is the lead singer and the songwriter of The Joggers, a rock band based in Portland, Oregon.